RecruitingNot ApplicableNCT07780760

Effect of Preoprative Nebulized Dexmedetomidine Compared to Nebulized Lidocaine in Attenuating Sore Throat Following Tonsillectomy In Childern.

Effect of Preoprative Nebulized Dexmedetomidine Compared to Nebulized Lidocaine in Attenuating Sore Throat Following Tonsillectomy In Childern. A Prospective, Randomized, Double-Blinded Trial.


Sponsor

Fayoum University Hospital

Enrollment

70 participants

Start Date

Sep 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of the study is to compare the effect of nebulized Dexmedetomidine compared to nebulized Lidocaine on postoperative sore throat in childern undergoing Tonsillectomy.


Eligibility

Sex: FEMALEMin Age: 3 YearsMax Age: 15 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Group D (dexmedetomidine group) and a drug called Group L (Lidocaine group) for people with dexmedetomidine analgesia, sore-throat, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 3 Years to 15 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGGroup D (dexmedetomidine group)

group D (Dexmedetomidine group) will recieve a dose of 1 mcg/kg

DRUGGroup L (Lidocaine group)

will recieve Lidocaine 2%, 1 mg/kg


Locations(1)

Fayoum university Hospitl

Al Fayyum, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07780760


Related Trials